The DMD Hub helps sites meet industry requirements for DMD clinical trials. We do this by providing training, mentoring and resources.
The Hub works collaboratively with industry partners to provide advice and support to sites that are setting up and running DMD clinical trials.
The DMD Hub helps industry by providing a flexible approach and tailored support, which includes:
Increased trial capacity and site availability
Facilitating selection of sites able and willing to run clinical trials
Supporting the development of sites which can conduct non-ambulant trials
Promoting communication with the patient community
High Quality Training at sites across the UK
Providing tools to help plan and conduct trials via the evolving Hub Toolkit
Working with TREAT-NMD to develop tools, which will accelerate clinical trials in the neuromuscular field
Provides the same standards across all DMD Hub sites
Advising on clinical trial approval process, based on prior experience, to accelerate the timelines as much as possible
Collaborating with TREAT-NMD Advisory Committee for Therapeutics (TACT) to provide advice on protocol development
In its first year of operation, the DMD-Hub has worked successfully with industry to increase DMD-Hub site capabilities.
During 2018, we have already carried out site feasibility enquires for companies interested in initiating or expanding trial capacity in the UK. The Hub has also worked closely with academic principal investigators (PIs) to develop academic-led clinical trials.
Our collaborators to date include:
If you would like to discuss how the DMD-Hub can help facilitate clinical trials in the UK for your company, please contact Emma Heslop (DMD-Hub Manager).